Phillips James M Jr - Net Worth and Insider Trading

Phillips James M Jr Net Worth

The estimated net worth of Phillips James M Jr is at least $328,350 dollars as of 2024-11-10. Phillips James M Jr is the Secretary of Arrowhead Pharmaceuticals Inc and owns about 15,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $328,350. Details can be seen in Phillips James M Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Phillips James M Jr has not made any transactions after 2004-01-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Phillips James M Jr

Phillips James M Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Phillips James M Jr owns 1 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) .

Click here to see the complete history of Phillips James M Jr’s form 4 insider trades.

Insider Ownership Summary of Phillips James M Jr

Ticker	Comapny	Transaction Date	Type of Owner
ARWR	Arrowhead Pharmaceuticals Inc	2004-01-30	director & Secretary

Phillips James M Jr Latest Holdings Summary

Phillips James M Jr currently owns a total of 1 stock. Phillips James M Jr owns 15,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 30, 2004, with a value of $328,350.

Latest Holdings of Phillips James M Jr

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ARWR	Arrowhead Pharmaceuticals Inc	2004-01-30	15,000	21.89	328,350

Holding Weightings of Phillips James M Jr

Phillips James M Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Phillips James M Jr has made a total of 0 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 0 shares on January 30, 2004, which brought Phillips James M Jr around $0.

Insider Trading History of Phillips James M Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Phillips James M Jr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Phillips James M Jr Ownership Network

Ownership Network List of Phillips James M Jr

No Data

Ownership Network Relation of Phillips James M Jr

Phillips James M Jr Owned Company Details

What does Arrowhead Pharmaceuticals Inc do?

Who are the key executives at Arrowhead Pharmaceuticals Inc?

Phillips James M Jr is the director & Secretary of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include Chief Commercial Officer Tracie Oliver , other: Senior Vice President James C Hamilton , and CFO Kenneth Allen Myszkowski .

Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary

Over the past 18 months, Phillips James M Jr made no insider transaction in Arrowhead Pharmaceuticals Inc (ARWR). Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 161,544 shares made by Christopher Richard Anzalone , a net sale of 55,383 shares made by James C Hamilton , and a net sale of 71,104 shares made by Kenneth Allen Myszkowski .

In summary, during the past 3 months, insiders sold 0 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 385,678 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 382,678 shares.

Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arrowhead Pharmaceuticals Inc Insider Transactions

No Available Data

Phillips James M Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Phillips James M Jr. Currently GuruFocus does not have mailing address information for Phillips James M Jr.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.